PedAM

Pediatric Disease Annotations & Medicines


	pollen allergy

Disease ID	640
Disease	pollen allergy
Definition	seasonal variety of allergic rhinitis, marked by acute conjunctivitis with lacrimation and itching; regarded as an allergic condition triggered by specific allergens.
Synonym	allergic rhinitides, seasonal allergic rhinitis caused by pollen allergic rhinitis caused by pollen (disorder) allergic rhinitis caused by pollens allergic rhinitis due to pollen allergic rhinitis due to pollen (disorder) allergic rhinitis due to pollens allergic rhinitis, seasonal allergies pollen allergies, pollen allergy pollen allergy to pollen allergy to pollen (disorder) allergy, pollen fever hay fever, hay hay fever hay fever - pollens hayfever pollen allergies pollenosis pollinoses pollinosis pollinosis (& allergic rhinitis due to pollens) rhinitides, seasonal allergic rhinitis due to pollen rhinitis, allergic, seasonal rhinitis, allergic, seasonal [disease/finding] rhinitis, seasonal allergic seasonal allergic reaction seasonal allergic rhinitides seasonal allergic rhinitis seasonal allergic rhinitis (disorder) seasonal allergic rhinitis (disorder) [ambiguous] seasonal allergic rhinitis [ambiguous] seasonal allergies seasonal allergy seasonal allergy (disorder) spasmodic rhinorrhea spasmodic rhinorrhoea
DOID	DOID:4481 DOID:0060497
ICD10	ICD10CM:J30.1
UMLS	C0018621
MeSH	D006255
SNOMED-CT	SNOMEDCT_US_2016_09_01:21719001;SNOMEDCT_US_2016_09_01:367498001;SNOMEDCT_US_2016_09_01:300910009;SNOMEDCT_US_2016_09_01:444316004
Comorbidity	UMLS \| Disease \| Sentences' Count(Total Sentences:7) C0035455 \| rhinitis \| 6 C2607914 \| allergic rhinitis \| 6 C0004096 \| asthma \| 4 C0016470 \| food allergy \| 2 C0018621 \| seasonal allergic rhinitis \| 2 C0011615 \| atopic eczema \| 1 C0013595 \| eczema \| 1
Curated Gene	Entrez_id \| Symbol \| Resource(Total Genes:10) CLEC16A \| 23274 \| GWASCAT SMAD3 \| 4088 \| GWASCAT TLR1 \| 7096 \| GWASCAT IKZF3 \| 22806 \| GWASCAT VAV3 \| 10451 \| GWASCAT XKR6 \| 286046 \| GWASCAT GSDMA \| 284110 \| GWASCAT CST1 \| 1469 \| CTD_human IL1RL1 \| 9173 \| GWASCAT TNS1 \| 7145 \| GWASCAT
Inferring Gene	Entrez_id \| Symbol \| Resource(Total Genes:23) 3119 \| HLA-DQB1 \| infer 3123 \| HLA-DRB1 \| infer 27 \| ABL2 \| infer 915 \| CD3D \| infer 23274 \| CLEC16A \| infer 1437 \| CSF2 \| infer 1493 \| CTLA4 \| infer 1767 \| DNAH5 \| infer 955 \| ENTPD6 \| infer 2060 \| EPS15 \| infer 2737 \| GLI3 \| infer 29851 \| ICOS \| infer 3596 \| IL13 \| infer 3558 \| IL2 \| infer 3565 \| IL4 \| infer 3567 \| IL5 \| infer 3702 \| ITK \| infer 652974 \| RPL17P2 \| infer 653737 \| RPL21P119 \| infer 644146 \| RPS14P8 \| infer 6278 \| S100A7 \| infer 91137 \| SLC25A46 \| infer 85480 \| TSLP \| infer
Text Mined Gene	Entrez_id \| Symbol \| Score \| Resource(Total Genes:109) 51087 \| YBX2 \| DISEASES 3385 \| ICAM3 \| DISEASES 3566 \| IL4R \| DISEASES 9567 \| GTPBP1 \| DISEASES 638 \| BIK \| DISEASES 3560 \| IL2RB \| DISEASES 6554 \| SLC10A1 \| DISEASES 10423 \| CDIPT \| DISEASES 973 \| CD79A \| DISEASES 10282 \| BET1 \| DISEASES 969 \| CD69 \| DISEASES 3565 \| IL4 \| DISEASES 3567 \| IL5 \| DISEASES 9173 \| IL1RL1 \| DISEASES 5273 \| SERPINB10 \| DISEASES 3598 \| IL13RA2 \| DISEASES 6626 \| SNRPA \| DISEASES 6351 \| CCL4 \| DISEASES 1215 \| CMA1 \| DISEASES 967 \| CD63 \| DISEASES 80896 \| NPL \| DISEASES 27348 \| TOR1B \| DISEASES 5082 \| PDCL \| DISEASES 7097 \| TLR2 \| DISEASES 4016 \| LOXL1 \| DISEASES 7011 \| TEP1 \| DISEASES 55717 \| WDR11 \| DISEASES 27143 \| PALD1 \| DISEASES 975 \| CD81 \| DISEASES 941 \| CD80 \| DISEASES 3383 \| ICAM1 \| DISEASES 2162 \| F13A1 \| DISEASES 939 \| CD27 \| DISEASES 9611 \| NCOR1 \| DISEASES 9775 \| EIF4A3 \| DISEASES 2206 \| MS4A2 \| DISEASES 7292 \| TNFSF4 \| DISEASES 11309 \| SLCO2B1 \| DISEASES 6352 \| CCL5 \| DISEASES 29765 \| TMOD4 \| DISEASES 152185 \| SPICE1 \| DISEASES 213 \| ALB \| DISEASES 3562 \| IL3 \| DISEASES 5267 \| SERPINA4 \| DISEASES 94274 \| PPP1R14A \| DISEASES 6037 \| RNASE3 \| DISEASES 10879 \| SMR3B \| DISEASES 3603 \| IL16 \| DISEASES 6036 \| RNASE2 \| DISEASES 375611 \| SLC26A5 \| DISEASES 3596 \| IL13 \| DISEASES 9482 \| STX8 \| DISEASES 8763 \| CD164 \| DISEASES 1657 \| DMXL1 \| DISEASES 9092 \| SART1 \| DISEASES 23166 \| STAB1 \| DISEASES 80199 \| FUZ \| DISEASES 1831 \| TSC22D3 \| DISEASES 4161 \| MC5R \| DISEASES 6470 \| SHMT1 \| DISEASES 3563 \| IL3RA \| DISEASES 8784 \| TNFRSF18 \| DISEASES 10871 \| CD300C \| DISEASES 942 \| CD86 \| DISEASES 54101 \| RIPK4 \| DISEASES 11251 \| PTGDR2 \| DISEASES 2289 \| FKBP5 \| DISEASES 84419 \| C15orf48 \| DISEASES 9588 \| PRDX6 \| DISEASES 5132 \| PDC \| DISEASES 2224 \| FDPS \| DISEASES 5169 \| ENPP3 \| DISEASES 6942 \| TCF20 \| DISEASES 51150 \| SDF4 \| DISEASES 3123 \| HLA-DRB1 \| DISEASES 11314 \| CD300A \| DISEASES 3135 \| HLA-G \| DISEASES 54106 \| TLR9 \| DISEASES 128239 \| IQGAP3 \| DISEASES 58505 \| OSTC \| DISEASES 1847 \| DUSP5 \| DISEASES 959 \| CD40LG \| DISEASES 6342 \| SCP2 \| DISEASES 3597 \| IL13RA1 \| DISEASES 6789 \| STK4 \| DISEASES 27095 \| TRAPPC3 \| DISEASES 7185 \| TRAF1 \| DISEASES 712 \| C1QA \| DISEASES 3127 \| HLA-DRB5 \| DISEASES 50943 \| FOXP3 \| DISEASES 160897 \| GPR180 \| DISEASES 2512 \| FTL \| DISEASES 2189 \| FANCG \| DISEASES 5212 \| VIT \| DISEASES 2874 \| GPS2 \| DISEASES 238 \| ALK \| DISEASES 1439 \| CSF2RB \| DISEASES 57703 \| CWC22 \| DISEASES 9564 \| BCAR1 \| DISEASES 3586 \| IL10 \| DISEASES 27333 \| GOLIM4 \| DISEASES 51428 \| DDX41 \| DISEASES 3620 \| IDO1 \| DISEASES 83695 \| RHNO1 \| DISEASES 1232 \| CCR3 \| DISEASES 11331 \| PHB2 \| DISEASES 387521 \| TMEM189 \| DISEASES 23186 \| RCOR1 \| DISEASES 100124700 \| HOTAIR \| DISEASES
Locus	(Waiting for update.)

Disease ID	640
Disease	pollen allergy
Integrated Phenotype	(Waiting for update.)
Text Mined Phenotype	HPO \| Name \| Sentences' Count(Total Phenotypes:5) HP:0012384 \| Nasal inflammation \| 6 HP:0012393 \| Allergy \| 6 HP:0003193 \| Allergic rhinitis \| 6 HP:0002099 \| Asthma \| 4 HP:0000964 \| Eczema \| 1

Disease ID	640
Disease	pollen allergy
Manually Symptom	(Waiting for update.)
Text Mined Symptom	UMLS \| Name \| Sentences' Count(Total Symptoms:2) C0035455 \| rhinitis \| 6 C0004096 \| asthma \| 4

Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)

All Snps(Total Genotypes:37)
snpId	pubmedId	geneId	geneSymbol	diseaseId	sourceId	sentence	score	Year	geneSymbol_dbSNP	CHROMOSOME	POS	REF	ALT
rs10197862	24388013	9173	IL1RL1	umls:C0018621	GWASCAT	Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype.	0.12	2013	IL1RL1	2	102350089	A	G
rs1044573	22036096	955	ENTPD6	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.002367032	2011	ENTPD6	20	25226018	A	G
rs12450323	24388013	22806	IKZF3	umls:C0018621	GWASCAT	Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype.	0.12	2013	IKZF3	17	39816455	G	T
rs1325195	22036096	27	ABL2	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.002367032	2011	ABL2	1	179102621	G	A
rs16997517	21071541	3598	IL13RA2	umls:C0018621	BeFree	Of 60 tagging single-nucleotide polymorphisms covering eight genes (CSF2, IL3, IL4, IL13, CSF2RB, IL4R, IL13RA1, IL13RA2), several were related to pollen allergies among controls: IL4R rs3024647 (dominant OR: 1.5; 95% CI: 1.0-2.3; P = 0.04), CSF2RB rs16997517 (dominant OR: 2.2; 95% CI: 1.0-4.7; P = 0.04), and IL13 rs1800925 (per-allele OR: 1.7; 95% CI: 1.3-2.4; P = 0.0007).	0.000271442	2011	CSF2RB	22	36937894	C	T
rs16997517	21071541	3596	IL13	umls:C0018621	BeFree	Of 60 tagging single-nucleotide polymorphisms covering eight genes (CSF2, IL3, IL4, IL13, CSF2RB, IL4R, IL13RA1, IL13RA2), several were related to pollen allergies among controls: IL4R rs3024647 (dominant OR: 1.5; 95% CI: 1.0-2.3; P = 0.04), CSF2RB rs16997517 (dominant OR: 2.2; 95% CI: 1.0-4.7; P = 0.04), and IL13 rs1800925 (per-allele OR: 1.7; 95% CI: 1.3-2.4; P = 0.0007).	0.00764398	2011	CSF2RB	22	36937894	C	T
rs16997517	21071541	1439	CSF2RB	umls:C0018621	BeFree	CSF2RB rs16997517 was directly related to pollen allergies in controls and to reduced SCC risk.	0.000271442	2011	CSF2RB	22	36937894	C	T
rs16997517	21071541	3566	IL4R	umls:C0018621	BeFree	Of 60 tagging single-nucleotide polymorphisms covering eight genes (CSF2, IL3, IL4, IL13, CSF2RB, IL4R, IL13RA1, IL13RA2), several were related to pollen allergies among controls: IL4R rs3024647 (dominant OR: 1.5; 95% CI: 1.0-2.3; P = 0.04), CSF2RB rs16997517 (dominant OR: 2.2; 95% CI: 1.0-4.7; P = 0.04), and IL13 rs1800925 (per-allele OR: 1.7; 95% CI: 1.3-2.4; P = 0.0007).	0.003181358	2011	CSF2RB	22	36937894	C	T
rs17294280	24388013	4088	SMAD3	umls:C0018621	GWASCAT	Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype.	0.12	2013	SMAD3	15	67175947	A	G
rs17513503	22036096	91137	SLC25A46	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.002367032	2011	NA	5	110810746	C	G
rs1800925	21071541	3598	IL13RA2	umls:C0018621	BeFree	Of 60 tagging single-nucleotide polymorphisms covering eight genes (CSF2, IL3, IL4, IL13, CSF2RB, IL4R, IL13RA1, IL13RA2), several were related to pollen allergies among controls: IL4R rs3024647 (dominant OR: 1.5; 95% CI: 1.0-2.3; P = 0.04), CSF2RB rs16997517 (dominant OR: 2.2; 95% CI: 1.0-4.7; P = 0.04), and IL13 rs1800925 (per-allele OR: 1.7; 95% CI: 1.3-2.4; P = 0.0007).	0.000271442	2011	IL13;LOC101927761	5	132657117	C	T
rs1800925	21071541	3566	IL4R	umls:C0018621	BeFree	Of 60 tagging single-nucleotide polymorphisms covering eight genes (CSF2, IL3, IL4, IL13, CSF2RB, IL4R, IL13RA1, IL13RA2), several were related to pollen allergies among controls: IL4R rs3024647 (dominant OR: 1.5; 95% CI: 1.0-2.3; P = 0.04), CSF2RB rs16997517 (dominant OR: 2.2; 95% CI: 1.0-4.7; P = 0.04), and IL13 rs1800925 (per-allele OR: 1.7; 95% CI: 1.3-2.4; P = 0.0007).	0.003181358	2011	IL13;LOC101927761	5	132657117	C	T
rs1800925	21071541	3596	IL13	umls:C0018621	BeFree	Of 60 tagging single-nucleotide polymorphisms covering eight genes (CSF2, IL3, IL4, IL13, CSF2RB, IL4R, IL13RA1, IL13RA2), several were related to pollen allergies among controls: IL4R rs3024647 (dominant OR: 1.5; 95% CI: 1.0-2.3; P = 0.04), CSF2RB rs16997517 (dominant OR: 2.2; 95% CI: 1.0-4.7; P = 0.04), and IL13 rs1800925 (per-allele OR: 1.7; 95% CI: 1.3-2.4; P = 0.0007).	0.00764398	2011	IL13;LOC101927761	5	132657117	C	T
rs1898671	22036096	85480	TSLP	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.002638474	2011	TSLP	5	111072304	C	T
rs2069772	22036096	3558	IL2	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.002638474	2011	IL2	4	122451978	T	C
rs2155219	22036096	2615	LRRC32	umls:C0018621	BeFree	Variants in a locus near chromosome 11 open reading frame 30 (C11orf30) and leucine-rich repeat containing 32 (LRRC32), which was previously associated with atopic dermatitis and eczema, were also strongly associated with both phenotypes (rs2155219; P(grass) = 9.4 × 10(-9); P(AR) = 3.8 × 10(-8)).	0.000542884	2011	NA	11	76588150	G	T
rs2155219	22036096	56946	C11orf30	umls:C0018621	GAD	[Variants in a locus near chromosome 11 open reading frame 30 (C11orf30) and leucine-rich repeat containing 32 (LRRC32), which was previously associated with atopic dermatitis and eczema, were also strongly associated with both phenotypes (rs2155219; P(grass)A = 9.4 A 10(-9); P(AR)A = 3.8 A 10(-8)).]	0.002638474	2011	NA	11	76588150	G	T
rs2155219	22036096	56946	C11orf30	umls:C0018621	BeFree	Variants in a locus near chromosome 11 open reading frame 30 (C11orf30) and leucine-rich repeat containing 32 (LRRC32), which was previously associated with atopic dermatitis and eczema, were also strongly associated with both phenotypes (rs2155219; P(grass) = 9.4 × 10(-9); P(AR) = 3.8 × 10(-8)).	0.002638474	2011	NA	11	76588150	G	T
rs3024647	21071541	3566	IL4R	umls:C0018621	BeFree	Of 60 tagging single-nucleotide polymorphisms covering eight genes (CSF2, IL3, IL4, IL13, CSF2RB, IL4R, IL13RA1, IL13RA2), several were related to pollen allergies among controls: IL4R rs3024647 (dominant OR: 1.5; 95% CI: 1.0-2.3; P = 0.04), CSF2RB rs16997517 (dominant OR: 2.2; 95% CI: 1.0-4.7; P = 0.04), and IL13 rs1800925 (per-allele OR: 1.7; 95% CI: 1.3-2.4; P = 0.0007).	0.003181358	2011	IL4R	16	27356651	G	A
rs3024647	21071541	3598	IL13RA2	umls:C0018621	BeFree	Of 60 tagging single-nucleotide polymorphisms covering eight genes (CSF2, IL3, IL4, IL13, CSF2RB, IL4R, IL13RA1, IL13RA2), several were related to pollen allergies among controls: IL4R rs3024647 (dominant OR: 1.5; 95% CI: 1.0-2.3; P = 0.04), CSF2RB rs16997517 (dominant OR: 2.2; 95% CI: 1.0-4.7; P = 0.04), and IL13 rs1800925 (per-allele OR: 1.7; 95% CI: 1.3-2.4; P = 0.0007).	0.000271442	2011	IL4R	16	27356651	G	A
rs3024647	21071541	3596	IL13	umls:C0018621	BeFree	Of 60 tagging single-nucleotide polymorphisms covering eight genes (CSF2, IL3, IL4, IL13, CSF2RB, IL4R, IL13RA1, IL13RA2), several were related to pollen allergies among controls: IL4R rs3024647 (dominant OR: 1.5; 95% CI: 1.0-2.3; P = 0.04), CSF2RB rs16997517 (dominant OR: 2.2; 95% CI: 1.0-4.7; P = 0.04), and IL13 rs1800925 (per-allele OR: 1.7; 95% CI: 1.3-2.4; P = 0.0007).	0.00764398	2011	IL4R	16	27356651	G	A
rs4724100	22036096	2737	GLI3	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.002367032	2011	GLI3	7	42225080	T	C
rs4833095	24388013	7096	TLR1	umls:C0018621	GWASCAT	Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype.	0.122367032	2013	TLR1	4	38798089	T	C
rs4986790	21103885	7099	TLR4	umls:C0018621	BeFree	Our objective was to determine the frequency of TNF-alpha -238, -308 G/A promoter and TLR-4 299 D/G and 399 T/I polymorphisms in healthy population and in patients with seasonal allergic rhinitis, and to examine its influences on serum TNF-alpha, TNF receptor-1, Fas, Fas-ligand, IgE levels and on clinical symptoms.	0.002909916	2011	TLR4	9	117713024	A	G
rs4986791	21103885	7099	TLR4	umls:C0018621	BeFree	Our objective was to determine the frequency of TNF-alpha -238, -308 G/A promoter and TLR-4 299 D/G and 399 T/I polymorphisms in healthy population and in patients with seasonal allergic rhinitis, and to examine its influences on serum TNF-alpha, TNF receptor-1, Fas, Fas-ligand, IgE levels and on clinical symptoms.	0.002909916	2011	TLR4	9	117713324	C	T
rs62026376	24388013	23274	CLEC16A	umls:C0018621	GWASCAT	At genome-wide significance, we identified 11 independent variants associated with the risk of having asthma with hay fever, including 2 associations reaching this level of significance with allergic disease for the first time: ZBTB10 (rs7009110; odds ratio [OR], 1.14; P = 4 × 10(-9)) and CLEC16A (rs62026376; OR, 1.17; P = 1 × 10(-8)).	0.122638474	2013	CLEC16A	16	11134855	C	T
rs62026376	24388013	23274	CLEC16A	umls:C0018621	BeFree	At genome-wide significance, we identified 11 independent variants associated with the risk of having asthma with hay fever, including 2 associations reaching this level of significance with allergic disease for the first time: ZBTB10 (rs7009110; odds ratio [OR], 1.14; P = 4 × 10(-9)) and CLEC16A (rs62026376; OR, 1.17; P = 1 × 10(-8)).	0.122638474	2013	CLEC16A	16	11134855	C	T
rs6554809	22036096	1767	DNAH5	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.002367032	2011	DNAH5	5	13740867	C	T
rs6673480	22036096	2060	EPS15	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.002367032	2011	EPS15	1	51393570	C	T
rs6982751	24388013	286046	XKR6	umls:C0018621	GWASCAT	Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype.	0.12	2013	XKR6	8	10955964	C	G
rs7009110	24388013	23274	CLEC16A	umls:C0018621	BeFree	At genome-wide significance, we identified 11 independent variants associated with the risk of having asthma with hay fever, including 2 associations reaching this level of significance with allergic disease for the first time: ZBTB10 (rs7009110; odds ratio [OR], 1.14; P = 4 × 10(-9)) and CLEC16A (rs62026376; OR, 1.17; P = 1 × 10(-8)).	0.122638474	2013	NA	8	80379644	T	C
rs7212938	24388013	284110	GSDMA	umls:C0018621	GWASCAT	A variant near LRRC32 was a stronger risk factor for hay fever than for asthma, whereas the reverse was observed for variants in/near GSDMA and TSLP.	0.12	2013	GSDMA	17	39966427	G	A,T
rs7521681	24388013	10451	VAV3	umls:C0018621	GWASCAT	Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype.	0.12	2013	VAV3	1	107779913	G	A
rs76043829	24388013	7145	TNS1	umls:C0018621	GWASCAT	Single nucleotide polymorphisms with suggestive evidence for association with asthma with hay fever risk included rs41295115 near IL2RA (OR, 1.28; P = 5 × 10(-7)) and rs76043829 in TNS1 (OR, 1.23; P = 2 × 10(-6)).	0.12	2013	TNS1	2	217812863	G	A
rs7617456	22036096	348808	NPHP3-AS1	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.002367032	2011	NA	3	133009059	G	A
rs7775228	22036096	3119	HLA-DQB1	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.005005506	2011	NA	6	32690302	T	C
rs887864	22036096	23274	CLEC16A	umls:C0018621	GAD	[This relatively large meta-analysis of GWASs identified few loci associated with AR and grass sensitization. No birth order interaction was identified in the current analyses.]	0.122638474	2011	CLEC16A	16	11065028	G	C,A

GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)

GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)

Mapped by lexical matching(Total Items:0)
(Waiting for update.)

Mapped by homologous gene(Total Items:0)
(Waiting for update.)

Chemical(Total Drugs:3)
CUI	ChemicalName	ChemicalID	CasRN	DiseaseName	DiseaseID	DirectEvidence	PubMedIDs
C0018621	cetirizine	D017332	83881-51-0	rhinitis, allergic, seasonal	MESH:D006255	therapeutic	11034010
C0018621	loratadine	D017336	79794-75-5	rhinitis, allergic, seasonal	MESH:D006255	therapeutic	10400480
C0018621	terfenadine	D016593	50679-08-8	rhinitis, allergic, seasonal	MESH:D006255	therapeutic	1644069

FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)

FDA labeling changes(Total Drugs:0)
(Waiting for update.)